Literature DB >> 8764064

African green monkey kidney (Vero) cells provide an alternative host cell system for influenza A and B viruses.

E A Govorkova1, G Murti, B Meignier, C de Taisne, R G Webster.   

Abstract

The preparation of live, attenuated human influenza virus vaccines and of large quantities of inactivated vaccines after the emergence or reemergence of a pandemic influenza virus will require an alternative host cell system, because embryonated chicken eggs will likely be insufficient and suboptimal. Preliminary studies indicated that an African green monkey kidney cell line (Vero) is a suitable system for the primary isolation and cultivation of influenza A viruses (E. A. Govorkova, N. V. Kaverin, L. V. Gubareva, B. Meignier, and R. G. Webster, J. Infect. Dis. 172:250-253, 1995). We now demonstrate for the first time that Vero cells are suitable for isolation and productive replication of influenza B viruses and determine the biological and genetic properties of both influenza A and B viruses in Vero cells; additionally, we characterize the receptors on Vero cells compared with those on Madin-Darby canine kidney (MDCK) cells. Sequence analysis indicated that the hemagglutinin of Vero cell-derived influenza B viruses was identical to that of MDCK-grown counterparts but differed from that of egg-grown viruses at amino acid positions 196 to 198. Fluorescence-activated cell sorting analysis showed that although Vero cells possess predominantly alpha2,3 galactose-linked sialic acid, they are fully susceptible to infection with either human influenza A or B viruses. Moreover, all virus-specific polypeptides were synthesized in the same proportions in Vero cells as in MDCK cells. Electron microscopic and immunofluorescence studies confirmed that infected Vero cells undergo the same morphological changes as do other polarized epithelia] cells. Taken together, these results indicate that Vero cell lines could serve as an alternative host system for the cultivation of influenza A and B viruses, providing adequate quantities of either virus to meet the vaccine requirements imposed by an emerging pandemic.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8764064      PMCID: PMC190510     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Abortive infection of Vero cells by an influenza A virus (FPV).

Authors:  S C Lau; C Scholtissek
Journal:  Virology       Date:  1995-09-10       Impact factor: 3.616

2.  A host-cell-selected variant of influenza B virus with a single nucleotide substitution in HA affecting a potential glycosylation site was attenuated in virulence for volunteers.

Authors:  J S Oxford; G C Schild; T Corcoran; R Newman; D Major; J Robertson; J Bootman; P Higgins; W al-Nakib; D A Tyrrell
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

3.  Relative efficacy of embryonated eggs and cell culture for isolation of contemporary influenza viruses.

Authors:  A S Monto; H F Maassab; E R Bryan
Journal:  J Clin Microbiol       Date:  1981-01       Impact factor: 5.948

4.  Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface.

Authors:  R A Lamb; S L Zebedee; C D Richardson
Journal:  Cell       Date:  1985-03       Impact factor: 41.582

5.  Protein synthesis in Vero cells abortively infected with influenza B virus.

Authors:  K Nakamura; M Homma
Journal:  J Gen Virol       Date:  1981-09       Impact factor: 3.891

6.  Alterations in the hemagglutinin associated with adaptation of influenza B virus to growth in eggs.

Authors:  J S Robertson; C W Naeve; R G Webster; J S Bootman; R Newman; G C Schild
Journal:  Virology       Date:  1985-05       Impact factor: 3.616

7.  Differential infection of receptor-modified host cells by receptor-specific influenza viruses.

Authors:  S M Carroll; J C Paulson
Journal:  Virus Res       Date:  1985-09       Impact factor: 3.303

8.  Host cell-mediated variation in H3N2 influenza viruses.

Authors:  J M Katz; C W Naeve; R G Webster
Journal:  Virology       Date:  1987-02       Impact factor: 3.616

9.  Evidence for host-cell selection of influenza virus antigenic variants.

Authors:  G C Schild; J S Oxford; J C de Jong; R G Webster
Journal:  Nature       Date:  1983 Jun 23-29       Impact factor: 49.962

10.  Receptor determinants of human and animal influenza virus isolates: differences in receptor specificity of the H3 hemagglutinin based on species of origin.

Authors:  G N Rogers; J C Paulson
Journal:  Virology       Date:  1983-06       Impact factor: 3.616

View more
  46 in total

1.  Search for additional influenza virus to cell interactions.

Authors:  E M Rapoport; L V Mochalova; H-J Gabius; J Romanova; N V Bovin
Journal:  Glycoconj J       Date:  2006-02       Impact factor: 2.916

2.  Cell culture (Vero) derived whole virus (H5N1) vaccine based on wild-type virus strain induces cross-protective immune responses.

Authors:  Otfried Kistner; M Keith Howard; Martin Spruth; Walter Wodal; Peter Brühl; Marijan Gerencer; Brian A Crowe; Helga Savidis-Dacho; Ian Livey; Manfred Reiter; Ines Mayerhofer; Christa Tauer; Leopold Grillberger; Wolfgang Mundt; Falko G Falkner; P Noel Barrett
Journal:  Vaccine       Date:  2007-06-04       Impact factor: 3.641

Review 3.  Proteomic contributions to our understanding of vaccine and immune responses.

Authors:  Allison C Galassie; Andrew J Link
Journal:  Proteomics Clin Appl       Date:  2015-09-10       Impact factor: 3.494

Review 4.  Cell culture-based influenza vaccines: A necessary and indispensable investment for the future.

Authors:  Nagendra R Hegde
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

5.  Potential neoplastic evolution of Vero cells: in vivo and in vitro characterization.

Authors:  N A Andreani; S Renzi; G Piovani; P Ajmone Marsan; L Bomba; R Villa; M Ferrari; S Dotti
Journal:  Cytotechnology       Date:  2017-04-06       Impact factor: 2.058

6.  The roles of hemagglutinin Phe-95 in receptor binding and pathogenicity of influenza B virus.

Authors:  Fengyun Ni; Innocent Nnadi Mbawuike; Elena Kondrashkina; Qinghua Wang
Journal:  Virology       Date:  2013-12-22       Impact factor: 3.616

7.  A Y161F Hemagglutinin Substitution Increases Thermostability and Improves Yields of 2009 H1N1 Influenza A Virus in Cells.

Authors:  Feng Wen; Lei Li; Nan Zhao; Meng-Jung Chiang; Hang Xie; Jim Cooley; Richard Webby; Peng George Wang; Xiu-Feng Wan
Journal:  J Virol       Date:  2018-01-02       Impact factor: 5.103

8.  Overexpression of the alpha-2,6-sialyltransferase in MDCK cells increases influenza virus sensitivity to neuraminidase inhibitors.

Authors:  Mikhail Matrosovich; Tatyana Matrosovich; Jackie Carr; Noel A Roberts; Hans-Dieter Klenk
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

Review 9.  Cell-based influenza vaccines: progress to date.

Authors:  Jennifer M Audsley; Gregory A Tannock
Journal:  Drugs       Date:  2008       Impact factor: 9.546

10.  MDCK-SIAT1 cells show improved isolation rates for recent human influenza viruses compared to conventional MDCK cells.

Authors:  Ding Yuan Oh; Ian G Barr; Jenny A Mosse; Karen L Laurie
Journal:  J Clin Microbiol       Date:  2008-05-14       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.